ACT II: treatment of anal cancer comes full circle

Affiliations

Comment

Christopher G Willett et al. Lancet Oncol. 2013 May.

. 2013 May;14(6):443-5.

doi: 10.1016/S1470-2045(13)70121-9. Epub 2013 Apr 9.

¹ Department of Radiation Oncology, Duke University, Durham, NC 27710, USA. christopher.willett@duke.edu

No abstract available

Comment on

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D. James RD, et al. Lancet Oncol. 2013 May;14(6):516-24. doi: 10.1016/S1470-2045(13)70086-X. Epub 2013 Apr 9. Lancet Oncol. 2013. PMID: 23578724 Clinical Trial.